Your browser doesn't support javascript.
loading
The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia.
Neunert, Cindy E; Arnold, Donald M; Grace, Rachael F; Kuhne, Thomas; McCrae, Keith R; Terrell, Deirdra R.
Afiliación
  • Neunert CE; Department of Pediatrics, Columbia University Irving Medical Center, New York, NY.
  • Arnold DM; Department of Medicine, Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, ON, Canada.
  • Grace RF; Department of Pediatrics, Dana-Farber/Boston Children's Medical Center and Blood Disorders Center, Harvard Medical School, Boston, MA.
  • Kuhne T; Division of Oncology/Hematology, Pediatric Oncology/Hematology, University Children's Hospital Basel, Basel, Switzerland.
  • McCrae KR; Taussig Cancer Institute and Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, OH.
  • Terrell DR; Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Blood Adv ; 8(13): 3578-3582, 2024 Jul 09.
Article en En | MEDLINE | ID: mdl-38608258
ABSTRACT
ABSTRACT The 2019 American Society of Hematology (ASH) guidelines for immune thrombocytopenia (ITP) included recommendations on the management of adults (recommendations 1-9) and children (recommendations 10-21) with primary ITP . We describe here the results of a review of the 2019 guidelines by a working group of experts requested by ASH to inform decision-making about the need for and timing of a guideline revision. An updated Medline and Embase search applied the same search terms as in the 2019 ASH guidelines, limited to systematic reviews and clinical trials, from May 2017 to July 2022. There were 193 studies identified, 102 underwent abstract reviews, and 54 full reviews. Each study was assessed based on relevance to the previous recommendation with regard to the population, prioritized outcomes, new outcomes, and study design. Reviewers assessed if the data would change the strength or the directionality of the existing recommendation or merit development of a new recommendation. Based on this review, the ASH Committee on Quality endorsed a focused update on second-line management for adults with ITP. In addition, there will be continued annual monitoring and reviewing of the 2019 ASH guidelines on ITP in full to evaluate when there is sufficient new evidence to warrant additional revisions.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática / Guías de Práctica Clínica como Asunto / Hematología Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Púrpura Trombocitopénica Idiopática / Guías de Práctica Clínica como Asunto / Hematología Límite: Adult / Humans País/Región como asunto: America do norte Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos